We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Subsidiary Recalls Mislabeled Drugs

Law360 (March 29, 2011, 5:15 PM EDT) -- A generic-drug maker subsidiary of Pfizer Inc. on Saturday announced the voluntary recall of a drug lot including Citalopram and Finasteride tablets because bottles were mislabeled.

The recall covers medicines with lot number FI0510058-A on the label, which includes bottles of Citalopram 10 mg tablets and Finasteride 5 mg tablets distributed in the U.S., Greenstone LLC said in a statement.

The company asked patients to return bottles of the drugs with that number to a pharmacist.

Greenstone said incorrect labels may have been placed on the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.